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Background: Patients are increasingly seen as active partners in healthcare. While patient involvement in individual
clinical decisions has been extensively studied, no trial has assessed how patients can effectively be involved in
collective healthcare decisions affecting the population. The goal of this study was to test the impact of involving
patients in setting healthcare improvement priorities for chronic care at the community level.
Methods: Design: Cluster randomized controlled trial. Local communities were randomized in intervention (priority
setting with patient involvement) and control sites (no patient involvement). Setting: Communities in a canadian
region were required to set priorities for improving chronic disease management in primary care, from a list of 37
validated quality indicators. Intervention: Patients were consulted in writing, before participating in face-to-face
deliberation with professionals. Control: Professionals established priorities among themselves, without patient
involvement. Participants: A total of 172 individuals from six communities participated in the study, including 83
chronic disease patients, and 89 health professionals. Outcomes: The primary outcome was the level of agreement
between patients’ and professionals’ priorities. Secondary outcomes included professionals’ intention to use the
selected quality indicators, and the costs of patient involvement.
Results: Priorities established with patients were more aligned with core generic components of the Medical Home
and Chronic Care Model, including: access to primary care, self-care support, patient participation in clinical decisions,
and partnership with community organizations (p < 0.01). Priorities established by professionals alone placed more
emphasis on the technical quality of single disease management. The involvement intervention fostered mutual
influence between patients and professionals, which resulted in a 41% increase in agreement on common priorities
(95%CI: +12% to +58%, p < 0.01). Professionals’ intention to use the selected quality indicators was similar in
intervention and control sites. Patient involvement increased the costs of the prioritization process by 17%, and
required 10% more time to reach consensus on common priorities.
Conclusions: Patient involvement can change priorities driving healthcare improvement at the population level. Future
research should test the generalizability of these findings to other contexts, and assess its impact on patient care.
Trial registration: The Netherlands National Trial Register #NTR2496.
Keywords: Patient participation, Quality improvement, Health policy, Primary care, Chronic diseases, Randomized trial* Correspondence: antoine.boivin@usherbrooke.ca
1Charles-Lemoyne Research Center, Department of Family and Emergency
Medicine, Université de Sherbrooke, Sherbrooke, Canada
2Scientific Institute for Quality of Healthcare, Radboud University Nijmegen,
Nijmegen, the Netherlands
Full list of author information is available at the end of the article
© 2014 Boivin et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited.
Boivin et al. Implementation Science 2014, 9:24 Page 2 of 10
http://www.implementationscience.com/content/9/1/24Background
Patients are increasingly seen as active partners in
healthcare. The rise of chronic diseases highlights the
importance of productive interactions between patients
and health professionals [1,2]. Internationally, a number
of healthcare organizations are involving patients in
health services delivery and policy decisions, including:
guideline and quality indicator development, program
development and evaluation, quality improvement, and
funding priorities [3-8]. This growth in patient involve-
ment includes large national organizations (e.g., Patient
Centered Outcomes Research Institute, and the National
Institute for Clinical Excellence), as well as local
healthcare organizations (e.g., Primary Care Trusts,
and Patient-Centered Medical Homes) [9-11].
While patient involvement is widely advocated, its
actual impact on healthcare delivery and policy decisions
is largely unknown. In the past decades, over 200 trial
have assessed the impact of involving patients in individ-
ual clinical decisions (e.g., patient decision aids, self-
management support, and health education) [12-18]. In
contrast, no trial assessed the impact of patient involve-
ment on collective healthcare decisions affecting the
population [19-26]. As a result, the latest Cochrane re-
view on this topic concluded that there is ‘a huge gap in
the evidence from comparative studies about desirable
and adverse effects of [patient] involvement in health-
care decisions at the population level’ [19].
Deliberation theory posits that effective patient in-
volvement could foster mutual influence and increased
agreement between patients and professionals, resulting
in collective decisions about healthcare services and
policies that are more acceptable by those affected
[24,27,28]. A number of case reports and observational
studies have tested this hypothesis with conflicting results
[19,21-24,29,30]. Several challenges have been identified
to support patient involvement at the population level.
First, lack of understanding of scientific literature or
resource implications could lead to unrealistic decisions
[21]. Unbalanced recruitment may underrepresent the
views of vulnerable patients with complex conditions or
from disadvantaged socio-economic groups [31]. Finally, a
number of critics doubt that patients can actually influ-
ence professionals’ decisions and have an impact on col-
lective healthcare choices.
This article reports on results of the first trial of
patient involvement in collective healthcare decisions
affecting the population. Our primary objective was to
assess the impact of patient involvement on healthcare
improvement priorities at the community level. We
hypothesized that patient involvement would result in
mutual influence between patients and professionals,
and increase agreement on common improvement
priorities.Methods
Study setting
This study was implemented in a real-world priority-
setting exercise organized by the Regional Health Authority
of Abitibi-Témiscamingue (Québec), Canada. The region
has a population of 145,000 people, and is divided into six
local communitites. Local Health and Social Services
Centers are responsible for primary healthcare delivery
in each of these communitites through direct service
provision and contract with primary care providers [32].
In 2010–2011, the Regional Health Authority required its
six local Health and Social Services Centers to set prior-
ities for improving chronic disease prevention and man-
agement in primary care. Each Health and Social Services
Center could choose its own improvement priorities from
a list of 37 validated quality indicators. Selected priorities
were incorporated in their financial accountability con-
tracts with the Regional Health Authority.
Design
We conducted a cluster-randomized controlled trial
comparing healthcare improvement priority-setting with
and without patient involvement (Figure 1). At baseline,
we collected patients’ priorities from all participating
sites. Health and Social Services Centers were then ran-
domized in intervention sites (priority-setting with pa-
tient involvement) and control sites (priority-setting by
professionals alone, without patient involvement).
Our detailed study protocol has been published else-
where [33]. We pilot-tested our intervention with 27
participants (15 patients and 12 professionals) in a pilot
site outside of the study region, and tested our research
instruments with an additional 21 participants (11 pa-
tients and 10 professionals) [33]. The study was con-
ducted between January 2010 and May 2011 and was
approved by the Université du Québec en Abitibi-
Témiscamingue ethics committee.
Quality indicators used as healthcare improvement
priorities
In preparation for the trial, we conducted a systematic
review of validated quality indicators for chronic disease
prevention and management in primary care (including
diabetes, chronic obstructive pulmonary disease, and
cardiovascular disease) [33]. A total of 1,489 individual
quality indicators were identified, 801 of which met our
inclusion criteria. A panel of five experts (two physicians,
two managers, and one information specialist) independ-
ently rated each indicator based on its measurability with
existing information systems, and applicability to the
canadian primary care context. The comprehensiveness
of this preliminary indicator set was tested with a group
of nine patients and 11 professionals to ensure that it in-






• Receive feedback on patients' consultation
• Deliberate on local improvement priorities 
   with patients and professionals 
Control (No patient involvement)
n=3 Study Sites
n=45 Professionals
• No feedback on patients' consultation
• Deliberate on local improvement priorities 
   with professionals only
Baseline Patient Consultation
One-day meetings conducted in all study sites (n=6)
n=83 Patients
• Share individual patients' experience of care
• Receive information about local primary care services
• Vote on local healthcare improvement priorities ("patients' consultation")
Outcomes
1. Healthcare improvement priorities
2. Intention to use the selected quality indicators 
3. Costs of priority-setting 
Figure 1 Trial overview. Patients and professionals were recruited from 6 eligible Health and Social Services Centers. At baseline, patients from all
sites were consulted by vote on their baseline priorities. Health and Social Services Centers were then randomized in intervention (priority-setting with
patient involvement) and control sites (priority-setting without patient involvement).
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comments. The final list of indicators included 37 quality
indicators grouped into five domains: access, continuity
and integration of care, technical quality of disease pre-
vention and management, interpersonal relationships, and
outcomes. Details of the quality indicators used in the trial
are available at: www.implementationscience.com/content/
6/1/45/additional [33].
Recruitment
We sought to recruit the whole population of available
study sites in the region (target: six communities). Within
each study site, we created a recruitment team composed
of the medical director, the local chief executive officer, a
manager in charge of chronic disease services, and a pa-
tient sitting on the Health and Social Services Center’s
user committee. Recruitment teams were responsible
for identifying a diversified pool of potential participants
through open advertizing, healthcare and patient organi-
zations, and snowballing technique [34].
Selection of participants was conducted by a blinded
research assistant, before randomization. The research
assistant contacted potential participating patients, col-
lected socio-demographic characteristics, confirmed eli-
gibility criteria, and selected patients using stratified
random selection to ensure a balanced representation of
age, gender, socio-economic condition, and health status.
We sought to recruit patients targeted by chronic dis-
ease prevention and management services, including:
healthy adults without chronic disease; patients withuncomplicated chronic disease (diabetes, chronic ob-
structive pulmonary disease, or cardiovascular disease);
and patients with complex chronic conditions hospital-
ized in the previous year. Patients who trained or
worked as a health professional were excluded. Profes-
sionals were selected to include a balanced group of
clinicians and managers involved in chronic disease pre-
vention and management, including: primary care physi-
cians, allied health professionals directly involved in
patient care, managers responsible for chronic disease ser-
vices and existing information systems, and the chief ex-
ecutive officer of each Health and Social Services Center.
Patients consultation meetings
A patient consultation meeting was conducted in all
sites before randomization (Figure 1). This one-day pa-
tient consultation meeting (target = 15 patients/site) was
facilitated by an expert moderator. Patients recounted
their personal experiences of care in relation with chronic
disease prevention and management, received information
about primary care services from their community, and
were consulted individually by vote to select five quality
indicators that they believed should be prioritized for
healthcare improvement in their community (‘baseline
patient consultation’).
This patient consultation meeting had two functions.
First, it was used for outcome assessment in intervention
and control sites, by providing baseline data on patients’
priorities for healthcare improvement. Second, the patient
consultation meeting was a component of the involvement
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participate in deliberation meetings with professionals.
Randomization
Blocked randomization [35] of study sites was performed
after participants’ recruitment, and after completion of
the patients’ baseline consultation meetings. The random
allocation sequence was generated by an independent
expert through a randomization software [36]. Partici-
pants were thereafter unblinded to their assignment.
Participants were required not to disclose any informa-
tion from meetings until completion of the trial, which
we verified at the end of the study. Study sites were
more than 100 km apart from one another, and we
found no evidence of contamination between interven-
tion and control sites.
Intervention
In intervention sites, Health and Social Services Centers
established their improvement priorities with patient in-
volvement. Our patient involvement intervention com-
bined public consultation and participation methods
[37], as follows: 1) professionals received feedback on
priorities collected from all patients in the baseline
consultation meeting; and 2) professionals and patients
participated in a two-day deliberation meeting to agree
on healthcare improvement priorities for their com-
munity, using nominal group technique [38]. Patients
who participated in the baseline consultation meeting
were invited to participate in the deliberation meeting
(target = five patients/site) and were selected by a re-
search assistant through stratified random sampling to
include a balanced representation of age, gender, health
status, and socio-economic conditions. Each Health and
Social Services Center was allowed to select its own prior-
ities. An expert moderator facilitated all meetings with
two co-moderators.
Control
Health and Social Services Centers in control sites estab-
lished their improvement priorities with professionals
only, without patient involvement. Professionals in con-
trol sites did not receive feedback on patients’ baseline
priorities. Professionals deliberated among themselves to
agree on healthcare improvement priorities in a two-day
deliberation meeting, using similar nominal group tech-
niques and moderators as in other sites.
Data collection and analysis
The primary study outcome was the level of agreement
between patients’ and professionals’ priorities. Secondary
outcomes included changes in priorities, professionals’
intentions to use quality indicators for healthcare im-
provement, and the costs of patient involvement.At baseline and at the end of the trial, each participant
was asked to identify five healthcare improvement prior-
ities from the list of 37 quality indicators. Priorities were
ranked based on the proportion of participants who
selected them. Agreement between patients’ and profes-
sionals’ priorities was calculated using the Spearman
correlation coefficient (0 = no agreement; 1 = perfect
agreement). Statistical differences in correlation coeffi-
cients between intervention and control sites were tested
using Fisher r-to-z transformation [39], and we used
multi-level analysis to account for the clustering of pri-
ority scores at the community level [40]. Differences in
improvement priorities were calculated from the pro-
portion of participants who selected each indicator, and
tested using Generalized Estimating Equation [41]. All
differences were assumed to be significant at p <0.05
(two-tailed test).
Professionals’ intention to use the selected priorities
for healthcare improvement were collected at the end of
the trial from an 11-item questionnaire measuring their
perception of the credibility, feasibility, and importance
of the selected quality indicators, as well as their
intention to use them for healthcare improvement. Each
item was scored on a seven-point Likert scale. Mean
score differences between intervention and control sites
were tested using multi-level analysis. We calculated the
marginal cost of patient involvement (patient recruit-
ment, training, and financial compensation of $100/day)
in relation with total project cost (health professionals’
salary, quality indicator menu development, moderation
of meetings, and project coordination). All costs were
calculated from the sponsoring organization’s perspec-
tive and assumed an average of 15 patients per training
meeting and five patients per deliberation meeting. All
statistical analyses were conducted with SAS 9.
Results
Participants
A total of 172 individuals from the six eligible sites par-
ticipated in the study. Characteristics of study sites and
individual participants were similar in intervention and
control groups (Table 1). Professionals (n = 89) included
managers (35%), physicians (13%), nurses (24%), and
allied health professionals (28%). Patients (n = 83) in-
cluded adults with different health status: 81% of pa-
tients had at least one chronic condition, 37% had three
chronic conditions or more, and 24% had been hospital-
ized at least once in the past year. Patients also included
individuals from diverse socio-economic status: 15% had
a family income of less than $20,000 and 58% had a
primary or high-school level education.
All patients (n = 83) participated in the baseline con-
sultation, and five to six patients per site (n = 17) also
participated in the deliberation meetings with intervention
Table 1 Characteristics of study sites and individual participants
Sites' characteristics Intervention Control
(n = 3) (n = 3)
Average population size 25.002 23.610
Family physician/population ratio 1/771 1/789
% population 65 y.o and above 15.6% 13.4%
% population with low income 12.3% 11.3%
% population with diabetes 6.5% 6.5%
Professionals' characteristics Intervention Control
(n = 44) (n = 45)
n (%) n (%)
Age
20 to 44 years 21 (47.7) 19 (48.7)
45 to 64 years 20 (45.5) 20 (51.3)
65 years or more 3 (6.8) 0 (0.0)
Gender
Male 9 (20.5) 10 (23.3)
Female 35 (79.5) 33 (76.7)
Type of work
Physician 6 (13.6) 6 (13.3)
Nurse 11 (25.0) 10 (22.2)
Allied health professional 11 (25.0) 14 (31.1)
Manager 16 (36.4) 15 (33.3)
Patients’ characteristics Baseline consultation Deliberation
(n = 83) (n = 17)
n (%) n (%)
Age
20 to 44 years 12 (14.6) 3 (18.8)
45 to 64 years 44 (53.7) 9 (56.3)
65 years or more 26 (31.7) 4 (25.0)
Gender
Male 36 (43.4) 10 (58.8)
Female 47 (56.6) 7 (41.2)
Family income
Less than 20 000 $ 16 (20.0) 3 (17.6)
From 20 000 $ up to 39 999 $ 29 (36.3) 8 (47.1)
From 40 000 $ up to 59 999 $ 13 (16.3) 4 (23.5)
60 000 $ or more 22 (27.5) 2 (11.8)
Education level
Primary school 12 (14.8) 0 (0.0)
High school 35 (43.2) 7 (41.2)
College or University 34 (42.0) 10 (58.8)
Specific chronic conditions
Arthritis 13 (15.7) 3 (17.6)
Cardiovascular disease 19 (22.9) 3 (17.6)
Chronic pain 11 (13.3) 3 (17.6)
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Table 1 Characteristics of study sites and individual participants (Continued)
Diabetes 30 (36.1) 2 (11.8)
Dyslipidemia 22 (26.5) 5 (29.4)
Hypertension 30 (36.1) 6 (35.3)
Mood disorder 9 (10.8) 1 (5.9)
Pulmonary disease 17 (20.5) 1 (5.9)
Other 24 (28.9) 3 (17.6)
Number of chronic conditions
0 16 (19.3) 5 (29.4)
1 21 (25.3) 5 (29.4)
2 or more 46 (55.4) 7 (41.2)
Hospitalisations in the past 12 months
0 62 (76.5) 13 (76.5)
1 10 (12.3) 2 (11.8)
2 or more 9 (11.1) 2 (11.8)
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one professional did not.
Healthcare improvement priorities
Patients’ baseline priorities were different from those of
professionals (Figure 2). Patients placed more importance
than professionals on access to primary care, respect and
empathy, time available in the consultation, and treatment
costs (p < 0.01).
At the end of the trial, intervention sites’ priorities
identified by patients with professionals were signifi-
cantly different from control sites’ priorities identified by
professionals alone (Figure 3). Priorities established with
patients placed more importance on generic aspects of
quality, including access to primary care, self-care sup-
port, patient participation in clinical decision-making,
and partnership with community organizations (p < 0.01).
Priorities established by professionals alone placed more
emphasis on reducing emergency room visits, collabor-
ation among healthcare organizations, and the technical
quality of single disease management (p < 0.01).
Differences in healthcare improvement priorities were
explained by a process of mutual influence between pa-
tients and professionals. Intervention sites selected pri-
orities that both patients and professionals could agreed
on. Accordingly, quality indicators that were initially
supported by both professionals and patients (e.g., family
physicians accepting new patients, patient participation
in clinical decision-making, and partnership with com-
munity organizations) were selected more often in inter-
vention sites. Initial disagreement between professionals
and patients resulted in changes of opinions on both sides.
For example, intervention sites’ professionals moved to-
ward priorities that were initially favored by patients (e.g.,timely appointment with a primary care provider) and
away from indicators that received little patient support
(e.g., collaboration among healthcare organizations). Pa-
tients’ priorities also moved toward indicators favored by
professionals (e.g., self-care support) and away from prior-
ities that received little professional support (e.g., respect
and empathy). As a result of this process of mutual in-
fluence, agreement between patients and professionals
increased by 41% favouring intervention sites (95%CI:
+12% to +58%; p < 0 .01) (Table 2).
Priorities at control sites reflected those selected by
professionals at baseline, and remained at odd with
patients’ priorities. For example, none of the control
sites’ professionals prioritized timely appointments with
a primary care provider, although this was the second
most important priority identified by patients.Intention to use
Professionals’ intention to use selected indicators for
healthcare improvement scored high in both interven-
tion and control groups (Additional file 1). There was no
difference in professionals’ perceptions of the credibility,
importance, and feasibility to use selected indicators as
local improvement targets.Costs
The average cost of public involvement was $9,427 per site.
Patient involvement increased the cost of the prioritization
process by 17% compared with priority-setting by profes-
sionals alone. Most of patient involvement costs were in-
curred by compensation of participants’ time, meal, and
travel expenses (34%), coordination of patient recruitment
(29%), and hiring of a professional facilitator (15%). Time
Figure 2 Baseline improvement priorities for patients and professionals. Baseline improvement priorities of patients (red) and professionals
(blue). **p < 0.01.
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10% longer in intervention sites.
Discussion
To the best of our knowledge, this is the first trial of pa-
tient involvement in collective healthcare improvement
decisions at the population level [19,20,22,23,25]. This
study shows that patient involvement can change prior-
ities driving healthcare improvement at the community
level. The involvement intervention fostered mutual influ-
ence and increased agreement between patients and pro-
fessionals. We found no evidence that patient involvement
adversely affected professionals’ intention to use the
selected quality indicators for improvement. However,
patient involvement required more time and dedicated
resources than priority-setting by professionals alone.
The observed impact of patient involvement on
priority-setting is clinically significant. Patient involvementshifted healthcare improvement priorities toward core
generic components of the Patient-Centered Medical
Home and Chronic Care Model, including timely access
to a regular primary care provider, self-care support,
patient participation in clinical decision-making, and
partnership with community organizations [42,43]. Pa-
tients’ ability to move priorities toward access to primary
care is meaningful from a North American perspective, as
recent international studies rank Canada and the US last
among developed countries on this quality dimension, a
problem with significant documented impacts on popula-
tion health [44,45].
Policy implications
This study is important as it is the first trial to document
the impact of patient involvement on strategic health-
care decisions affecting the population [19,21-23]. Such
experimental study is unique and makes a significant
Figure 3 Final improvement priorities in intervention and control sites. Final healthcare improvement priorities in intervention sites (purple)
and control sites (green). *p < 0,05 **p < 0,01.
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demonstrated that deliberation influences patients’ opin-
ions, this is the first trial evidence showing that patients
can influence professionals and have an actual impact on
collective decision-making [29]. Our ability to involve
vulnerable patients from disadvantaged socio-economic






Difference between intervention and control +9%
p value 0.62
Agreement between patients and professionals’ priorities at baseline and at the end
for the difference between intervention and control sites.important, and supports the feasibility of effectively in-
volving a broad range of stakeholders in complex policy
decisions [31].
These findings have practical implications for the
development of effective patient involvement interven-
tions in healthcare. This multi-faceted patient involve-
ment intervention required a structured recruitmentities
Agreement at the
end of the trial
Change in agreement
during the trial
r % change (95%CI)
0.69 +42% (+13%, +58%)
0.19 +1% (−25%, +27%)
+ 50% +41% (+12%, +58%)
<0.001 <0.01
of the trial (r = 0: no agreement, r = 1: perfect agreement). P value is reported
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a relatively large number of patients, small-group face-
to-face deliberation between professionals and patients,
financial compensation of participants, and moderation
by an expert facilitator. Setting priorities with patients
and professionals required more time and dedicated re-
sources than with professionals alone. Existing patient
involvement programs often lack some of these compo-
nents, which may explain variations of observed effects
in practice [21]. For example, it is common for one or
two patient representatives to sit on advisory committees
chaired by professionals, without structured patient
preparation. Results of this trial points toward some ‘key
ingredients’ that could support more effective patient in-
volvement in collective healthcare improvement and pol-
icy decisions, and those factors have been described in
details in a related publication [46].Study limitations and future research
The study sample size was small, and cluster randomization
further reduces statistical power. However, the trial proved
sufficient powered to test the impact of patient involvement
on priority-setting, because the observed effect size was
large. The small sample size may nonetheless have affected
our ability to detect differences in professionals’ intention
to use quality indicators.
While this study provides strong evidence that patient
involvement can change improvement priorities, we can-
not conclude that such differences will translate into
changes in healthcare delivery. An important area for
future research would therefore be to test, over a longer
time period, whether patient involvement can transform
healthcare services and have an impact on patient-
oriented outcomes.
Also, while patient involvement had an important
effect in this study, it is unknown if these results can be
generalized to other contexts. This involvement inter-
vention benefited from high-level policy support and
was implemented within relatively small communities,
which may have contributed to its effectiveness [47].
Caution is therefore required before extrapolating the
effects observed in this study to other involvement pro-
grams and contexts.Conclusions
In conclusion, this study shows that patient involvement
can change priorities driving healthcare improvement at
the community level. Effective patient involvement re-
quires time and dedicated resources. Future research
should assess the generalizability of these findings to
other contexts, and the impact of involvement interven-
tions on patient care.Additional file
Additional file 1: Professionals' intention to use the selected quality
indicators for healthcare improvement.
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